Loading clinical trials...
Loading clinical trials...
This phase I study will collect preliminary information on the activity and safety of cLSC. We will investigate the ability to manufacture and transplant cLSC onto the cornea successfully at the time ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University of California, Los Angeles
Collaborators
NCT05909735 · Limbal Stem-cell Deficiency, Congenital Aniridia
NCT03884569 · Limbal Stem-cell Deficiency
NCT04021134 · Limbal Stem-cell Deficiency
NCT04021875 · Limbal Stem-cell Deficiency
University of California
Los Angeles, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions